Published in J Virol on June 01, 1992
An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription. Proc Natl Acad Sci U S A (1997) 2.11
Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J Virol (1994) 2.09
Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J Virol (1994) 1.85
Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates. J Virol (1994) 1.72
Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol (1993) 1.71
Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription. J Virol (1994) 1.64
Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J Virol (1994) 1.58
Subgenomic negative-strand RNA function during mouse hepatitis virus infection. J Virol (2000) 1.48
Mutagenic analysis of the coronavirus intergenic consensus sequence. J Virol (1992) 1.45
Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J Virol (1993) 1.44
Equine arteritis virus subgenomic mRNA synthesis: analysis of leader-body junctions and replicative-form RNAs. J Virol (1996) 1.43
Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J Virol (1994) 1.41
Regulation of coronavirus mRNA transcription. J Virol (1995) 1.40
Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J (2000) 1.38
Transcription regulatory sequences and mRNA expression levels in the coronavirus transmissible gastroenteritis virus. J Virol (2002) 1.38
Investigation of the control of coronavirus subgenomic mRNA transcription by using T7-generated negative-sense RNA transcripts. J Virol (1995) 1.26
Unusual heterogeneity of leader-mRNA fusion in a murine coronavirus: implications for the mechanism of RNA transcription and recombination. J Virol (1994) 1.21
Evidence for coronavirus discontinuous transcription. J Virol (1994) 1.20
Insertion of a new transcriptional unit into the genome of mouse hepatitis virus. J Virol (1999) 1.19
Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication. Proc Natl Acad Sci U S A (2001) 1.15
The 3' untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA. J Virol (1996) 1.14
The effect of two closely inserted transcription consensus sequences on coronavirus transcription. J Virol (1995) 1.13
Long-distance RNA-RNA interactions and conserved sequence elements affect potato virus X plus-strand RNA accumulation. RNA (1999) 1.12
Mutual interference between genomic RNA replication and subgenomic mRNA transcription in brome mosaic virus. J Virol (2005) 1.03
Coronavirus transcription early in infection. J Virol (1998) 0.95
Two murine coronavirus genes suffice for viral RNA synthesis. J Virol (1995) 0.93
Regulation of relative abundance of arterivirus subgenomic mRNAs. J Virol (2004) 0.93
Replication of murine coronavirus defective interfering RNA from negative-strand transcripts. J Virol (1996) 0.87
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91
RNA of mouse hepatitis virus. J Virol (1978) 4.27
Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J Virol (1990) 4.19
The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc Natl Acad Sci U S A (1989) 3.65
The virus-specific intracellular RNA species of two murine coronaviruses: MHV-a59 and MHV-JHM. Virology (1981) 3.57
Coronavirus: organization, replication and expression of genome. Annu Rev Microbiol (1990) 3.20
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46
A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol (1991) 2.30
Minus-strand copies of replicating coronavirus mRNAs contain antileaders. J Virol (1991) 2.27
Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis. J Virol (1986) 2.26
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J Virol (1985) 2.10
Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87
Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J Virol (1988) 1.76
Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology (1988) 1.73
An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J (1990) 1.69
Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases. Virology (1984) 1.64
In vitro replication of mouse hepatitis virus strain A59. J Virol (1987) 1.46
RNA-dependent RNA polymerase activity in coronavirus- infected cells. J Virol (1982) 1.36
RNA-dependent RNA polymerase activity in murine coronavirus-infected cells. J Gen Virol (1983) 1.12
Synthesis of virus-specific RNA in permeabilized murine coronavirus-infected cells. Virology (1988) 0.96
Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu (1980) 5.03
A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a. Cell (1986) 4.88
DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des (2001) 4.54
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri. Infect Immun (1986) 4.33
Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci (1995) 3.56
Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51
Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology (2001) 3.40
virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence. J Bacteriol (1989) 3.31
Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J Bacteriol (1988) 3.24
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science (1986) 3.09
High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91
A dual transcriptional activation system for the 230 kb plasmid genes coding for virulence-associated antigens of Shigella flexneri. Mol Microbiol (1989) 2.81
The murine autoimmune diabetes model: NOD and related strains. Adv Immunol (1992) 2.80
Circadian waves of expression of the APRR1/TOC1 family of pseudo-response regulators in Arabidopsis thaliana: insight into the plant circadian clock. Plant Cell Physiol (2000) 2.61
Molecular characterization of proteins in detergent solutions. Biochemistry (1974) 2.36
Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis (1992) 2.30
DNA sequence and product analysis of the virF locus responsible for congo red binding and cell invasion in Shigella flexneri 2a. Infect Immun (1986) 2.22
Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J Virol (1985) 2.10
Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia (1984) 2.07
Molecular cloning of a genetic determinant for Congo red binding ability which is essential for the virulence of Shigella flexneri. Infect Immun (1986) 2.05
Identification and characterization of a coronavirus packaging signal. J Virol (1992) 2.01
Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis. Mol Microbiol (1993) 1.96
Double termination of the alimentary tract in females: a report of 12 cases and a literature review. J Pediatr Surg (1984) 1.90
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
Analysis of cis-acting sequences essential for coronavirus defective interfering RNA replication. Virology (1993) 1.89
Isolation, characterization, and mapping of Tn5 insertions into the 140-megadalton invasion plasmid defective in the mouse Sereny test in Shigella flexneri 2a. Infect Immun (1986) 1.81
The binding of deoxycholate and Triton X-100 to proteins. J Biol Chem (1973) 1.81
Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus. Eur J Biochem (1988) 1.80
Unique functions of Sonic hedgehog signaling during external genitalia development. Development (2001) 1.80
A gene (sleB) encoding a spore cortex-lytic enzyme from Bacillus subtilis and response of the enzyme to L-alanine-mediated germination. J Bacteriol (1996) 1.79
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Defective interfering particles of mouse hepatitis virus. Virology (1984) 1.76
Clinical significance of bronchial sensitivity to acetylcholine and histamine in bronchial asthma. J Allergy (1966) 1.73
Archaeal adaptation to higher temperatures revealed by genomic sequence of Thermoplasma volcanium. Proc Natl Acad Sci U S A (2000) 1.67
Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer (2001) 1.65
A germination-specific spore cortex-lytic enzyme from Bacillus cereus spores: cloning and sequencing of the gene and molecular characterization of the enzyme. J Bacteriol (1996) 1.65
A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology (2001) 1.64
Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum Mol Genet (1999) 1.60
Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J Virol (2001) 1.56
Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology (1999) 1.56
1 -Antitrypsin deficiency: a variant with no detectable 1 -antitrypsin. Science (1973) 1.53
Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med (1997) 1.51
Interaction of deoxycholate and of detergents with the coat protein of bacteriophage f1. J Biol Chem (1975) 1.49
Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol (1992) 1.49
Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem (2000) 1.46
Mutagenic analysis of the coronavirus intergenic consensus sequence. J Virol (1992) 1.45
Expression of a germination-specific amidase, SleB, of Bacilli in the forespore compartment of sporulating cells and its localization on the exterior side of the cortex in dormant spores. J Bacteriol (1999) 1.43
Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J (2010) 1.41
A gene (sleC) encoding a spore-cortex-lytic enzyme from Clostridium perfringens S40 spores; cloning, sequence analysis and molecular characterization. Microbiology (1995) 1.41
Poorly expressed CD2 antigen on the leukemic cells of adult T-cell leukemia and chronic lymphocytic leukemia of T-cell lineage. Leuk Res (1989) 1.41
Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells. Virology (1999) 1.39
Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation. Exp Hematol (1995) 1.39
Long-term regulation of interferon production by lymphocytes from children inoculated with live measles virus vaccine. J Infect Dis (1988) 1.39
Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J Virol (1999) 1.38
Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J Neurovirol (1995) 1.37
Characterization of a murine coronavirus defective interfering RNA internal cis-acting replication signal. J Virol (1995) 1.36
In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol (1988) 1.33
Effect of castration on the appearance of diabetes in NOD mouse. Jikken Dobutsu (1981) 1.33
Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy. Am J Physiol Heart Circ Physiol (2000) 1.33
Multiple recombination sites at the 5'-end of murine coronavirus RNA. Virology (1987) 1.32
Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ Res (1997) 1.32
Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis. Mol Microbiol (1997) 1.31
Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci (1995) 1.31
Detection of Escherichia coli O157:H7 from Musca domestica (Diptera: Muscidae) at a cattle farm in Japan. J Med Entomol (1999) 1.28
Purification and partial characterization of a spore cortex-lytic enzyme of Clostridium perfringens S40 spores. Biosci Biotechnol Biochem (1995) 1.27
The use of mice in the Sereny test as a virulence assay of shigellae and enteroinvasive Escherichia coli. Infect Immun (1986) 1.26
Molecular characterization of a germination-specific muramidase from Clostridium perfringens S40 spores and nucleotide sequence of the corresponding gene. J Bacteriol (1997) 1.25
Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc Natl Acad Sci U S A (1987) 1.24
RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells. J Virol (2000) 1.22
Evidence for coronavirus discontinuous transcription. J Virol (1994) 1.20
RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol (1988) 1.19
Biosynthesis, structure, and biological activities of envelope protein gp65 of murine coronavirus. Virology (1989) 1.19
Assembled coronavirus from complementation of two defective interfering RNAs. J Virol (1997) 1.18
Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology (1995) 1.17
A novel spore peptidoglycan hydrolase of Bacillus cereus: biochemical characterization and nucleotide sequence of the corresponding gene, sleL. J Bacteriol (2000) 1.17
Coronavirus: a jumping RNA transcription. Cold Spring Harb Symp Quant Biol (1987) 1.15
Coronavirus transcription mediated by sequences flanking the transcription consensus sequence. Virology (1996) 1.13
Generation and selection of coronavirus defective interfering RNA with large open reading frame by RNA recombination and possible editing. Virology (1993) 1.13
Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract (1990) 1.13
Murine coronavirus packaging signal confers packaging to nonviral RNA. J Virol (1997) 1.13
The effect of two closely inserted transcription consensus sequences on coronavirus transcription. J Virol (1995) 1.13
Phylogenetic diversity and similarity of active sites of Shiga toxin (stx) in Shiga toxin-producing Escherichia coli (STEC) isolates from humans and animals. Epidemiol Infect (2001) 1.12
RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc Natl Acad Sci U S A (1987) 1.11
Emphysema with hereditary alpha-1 antitrypsin deficiency masquerading as asthma. J Allergy (1970) 1.10
Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia. Bone Marrow Transplant (1997) 1.10
Membrane topology of coronavirus E protein. Virology (2001) 1.10
Detection and genetical characterization of Shiga toxin-producing Escherichia coli from wild deer. Microbiol Immunol (1998) 1.09
Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody. Jikken Dobutsu (1986) 1.08
Malignant change in the biliary tract after excision of choledochal cyst. Br J Surg (1997) 1.08
Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res (1997) 1.08
Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Jikken Dobutsu (1986) 1.06
Insulin and glucagon in spontaneously diabetic non-obese mice. Diabetologia (1984) 1.06